{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:24:37Z","timestamp":1793831077299,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00902-4","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:13:04Z","timestamp":1784884384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiomics, multi-species profiling, and animal validation identify mitoxyperilysis as a conserved therapeutic target in metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6495-4705","authenticated-orcid":false,"given":"Hanjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-848X","authenticated-orcid":false,"given":"Huijuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"2","key":"902_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2025.19615","volume":"335","author":"H Tilg","year":"2026","unstructured":"Tilg H, Petta S, Stefan N, Targher G. Metabolic dysfunction-associated steatotic liver disease in adults: a review. JAMA. 2026;335(2):163\u201374. https:\/\/doi.org\/10.1001\/jama.2025.19615.","journal-title":"JAMA"},{"issue":"12","key":"902_CR2","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1038\/s41588-025-02407-8","volume":"57","author":"Z Li","year":"2025","unstructured":"Li Z, Luo G, Gan C, Zhang H, Li L, Zhang X, et al. Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease. Nat Genet. 2025;57(12):3112\u201325. https:\/\/doi.org\/10.1038\/s41588-025-02407-8.","journal-title":"Nat Genet"},{"issue":"1","key":"902_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(22)00317-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"50","key":"902_CR4","doi-asserted-by":"publisher","first-page":"34375","DOI":"10.1021\/acsnano.4c13404","volume":"18","author":"C Zhang","year":"2024","unstructured":"Zhang C, Teng Y, Bai X, Tang M, Stewart W, Chen JJ, et al. Prevent and reverse metabolic dysfunction-associated steatohepatitis and hepatic fibrosis via mRNA-mediated liver-specific antibody therapy. ACS Nano. 2024;18(50):34375\u201390. https:\/\/doi.org\/10.1021\/acsnano.4c13404.","journal-title":"ACS Nano"},{"key":"902_CR5","doi-asserted-by":"publisher","first-page":"108054","DOI":"10.1016\/j.phrs.2025.108054","volume":"222","author":"Y Wang","year":"2025","unstructured":"Wang Y, Peng J. Proteolysis targeting chimera degraders target pseudokinases to treat metabolic dysfunction-associated steatohepatitis and fibrosis: mechanisms and therapeutic insights. Pharmacol Res. 2025;222:108054. https:\/\/doi.org\/10.1016\/j.phrs.2025.108054.","journal-title":"Pharmacol Res"},{"issue":"3","key":"902_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13679-022-00473-1","volume":"11","author":"AI Legaki","year":"2022","unstructured":"Legaki AI, Moustakas II, Sikorska M, Papadopoulos G, Velliou RI, Chatzigeorgiou A. Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease. Curr Obes Rep. 2022;11(3):126\u201343. https:\/\/doi.org\/10.1007\/s13679-022-00473-1.","journal-title":"Curr Obes Rep"},{"key":"902_CR7","doi-asserted-by":"crossref","unstructured":"Karkucinska-Wieckowska A, Simoes ICM, Kalinowski P, Lebiedzinska-Arciszewska M, Zieniewicz K, Milkiewicz P, et al. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: a complex relationship. Eur J Clin Invest. 2022;52(3):e13622.","DOI":"10.1111\/eci.13622"},{"issue":"1","key":"902_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12967-023-04627-0","volume":"21","author":"M Myint","year":"2023","unstructured":"Myint M, Oppedisano F, De Giorgi V, Kim BM, Marincola FM, Alter HJ, et al. Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions. J Transl Med. 2023;21(1):757. https:\/\/doi.org\/10.1186\/s12967-023-04627-0.","journal-title":"J Transl Med"},{"issue":"19","key":"902_CR9","doi-asserted-by":"publisher","first-page":"9715","DOI":"10.3390\/ijms26199715","volume":"26","author":"W Choi","year":"2025","unstructured":"Choi W, Woo GH, Kwon TH, Jeon JH. Obesity-driven metabolic disorders: the interplay of inflammation and mitochondrial dysfunction. Int J Mol Sci. 2025;26(19):9715. https:\/\/doi.org\/10.3390\/ijms26199715.","journal-title":"Int J Mol Sci"},{"key":"902_CR10","doi-asserted-by":"publisher","first-page":"101865","DOI":"10.1016\/j.molmet.2023.101865","volume":"80","author":"JB Zhang","year":"2024","unstructured":"Zhang JB, Zhang QR, Jin Q, Yang J, Lin SZ, Fan JG. Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitis. Mol Metab. 2024;80:101865. https:\/\/doi.org\/10.1016\/j.molmet.2023.101865.","journal-title":"Mol Metab"},{"key":"902_CR11","doi-asserted-by":"publisher","first-page":"126354","DOI":"10.1016\/j.ijpharm.2025.126354","volume":"686","author":"J Shi","year":"2025","unstructured":"Shi J, Yu B, Zhang J, Li Y, Chen W, Xu J, et al. Reactive oxygen species-responsive liver-targeting nanoparticles enhance the therapeutic effect of baicalin magnesium in metabolic dysfunction-associated fatty liver disease. Int J Pharm. 2025;686:126354. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126354.","journal-title":"Int J Pharm"},{"issue":"8","key":"902_CR12","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.7150\/ijbs.130535","volume":"22","author":"CY Wen","year":"2026","unstructured":"Wen CY, Wu MY, Tsai AP, Yong SB, Li CJ. Mitoxyperilysis: rethinking oxidative stress as a spatially constrained lethal signal. Int J Biol Sci. 2026;22(8):4139\u201343. https:\/\/doi.org\/10.7150\/ijbs.130535.","journal-title":"Int J Biol Sci"},{"issue":"25","key":"902_CR13","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1016\/j.cell.2025.11.002","volume":"188","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu J, Carisey AF, Chadchan SB, Lee HW, Malireddi RKS, et al. Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis. Cell. 2025;188(25):7155\u201374.e25. https:\/\/doi.org\/10.1016\/j.cell.2025.11.002.","journal-title":"Cell"},{"issue":"3","key":"902_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/HEP.0000000000000918","volume":"81","author":"K Sasaki","year":"2025","unstructured":"Sasaki K, Rooge S, Gunewardena S, Hintz JA, Ghosh P, Pulido Ruiz IA, et al. Kupffer cell diversity maintains liver function in alcohol-associated liver disease. Hepatology. 2025;81(3):870\u201387. https:\/\/doi.org\/10.1097\/HEP.0000000000000918.","journal-title":"Hepatology"},{"key":"902_CR15","doi-asserted-by":"publisher","unstructured":"Mooring M, Yeung GA, Luukkonen P, Liu S, Akbar MW, Zhang GJ, et al. Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis. Sci Transl Med. 2023;15(715):eade 3157. https:\/\/doi.org\/10.1126\/scitranslmed.ade3157.","DOI":"10.1126\/scitranslmed.ade3157"},{"issue":"5","key":"902_CR16","doi-asserted-by":"publisher","first-page":"115690","DOI":"10.1016\/j.celrep.2025.115690","volume":"44","author":"YW Chen","year":"2025","unstructured":"Chen YW, Ahn IS, Wang SS-M, Majid S, Diamante G, Cely I, et al. Multitissue single-cell analysis reveals differential cellular and molecular sensitivity between fructose and high-fat high-sucrose diets. Cell Rep. 2025;44(5):115690. https:\/\/doi.org\/10.1016\/j.celrep.2025.115690.","journal-title":"Cell Rep"},{"issue":"1","key":"902_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N, et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics. 2018;19(1):477. https:\/\/doi.org\/10.1186\/s12864-018-4772-0.","journal-title":"BMC Genomics"},{"issue":"6476","key":"902_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, Sikandar SS, Wesche DJ, Manjunath A, Bharadwaj A, Berger MJ, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020;367(6476):405\u201311. https:\/\/doi.org\/10.1126\/science.aax0249.","journal-title":"Science"},{"issue":"1","key":"902_CR19","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"902_CR20","doi-asserted-by":"publisher","unstructured":"Zheng R, Zhang Y, Tsuji T, Gao X, Shamsi F, Wagner A, et al. MEBOCOST maps metabolite-mediated intercellular communications using single-cell RNA-seq. Nucleic Acids Res. 2025;53(12). https:\/\/doi.org\/10.1093\/nar\/gkaf569.","DOI":"10.1093\/nar\/gkaf569"},{"key":"902_CR21","doi-asserted-by":"publisher","unstructured":"Min-DeBartolo J, Schlerman F, Akare S, Wang J, McMahon J, Zhan Y, et al. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH). PLoS One. 2019;14(12):e0226854. https:\/\/doi.org\/10.1371\/journal.pone.0226854.","DOI":"10.1371\/journal.pone.0226854"},{"key":"902_CR22","doi-asserted-by":"publisher","unstructured":"Matsumoto K, Kato Y, Hayashi M, Miura R, Monzen S, Chiba M. Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis. Mol Med Rep. 2022;26(5). https:\/\/doi.org\/10.3892\/mmr.2022.12841.","DOI":"10.3892\/mmr.2022.12841"},{"issue":"1","key":"902_CR23","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s41598-020-58030-6","volume":"10","author":"D Veyel","year":"2020","unstructured":"Veyel D, Wenger K, Broermann A, Bretschneider T, Luippold AH, Krawczyk B, et al. Biomarker discovery for chronic liver diseases by multi-omics \u2013 a preclinical case study. Sci Rep. 2020;10(1):1314. https:\/\/doi.org\/10.1038\/s41598-020-58030-6.","journal-title":"Sci Rep"},{"issue":"24","key":"902_CR24","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.3390\/nu15245056","volume":"15","author":"C Langhi","year":"2023","unstructured":"Langhi C, Vallier M, Otero YF, Maura M, Le Joubioux F, Groult H, et al. Totum-070, a polyphenol-rich plant extract, prevents hypercholesterolemia in high-fat diet-fed hamsters by inhibiting intestinal cholesterol absorption. Nutrients. 2023;15(24):5056. https:\/\/doi.org\/10.3390\/nu15245056.","journal-title":"Nutrients"},{"key":"902_CR25","doi-asserted-by":"publisher","unstructured":"Puppala S, Spradling-Reeves KD, Chan J, Birnbaum S, Newman DE, Comuzzie AG, et al. Hepatic transcript signatures predict atherosclerotic lesion burden prior to a 2-year high cholesterol, high fat diet challenge. PLoS One. 2022;17(8):e0271514. https:\/\/doi.org\/10.1371\/journal.pone.0271514.","DOI":"10.1371\/journal.pone.0271514"},{"key":"902_CR26","doi-asserted-by":"publisher","unstructured":"Feaver RE, Cole BK, Lawson MJ, Hoang SA, Marukian S, Blackman BR, et al. Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. JCI Insight. 2016;1(20):e90954. https:\/\/doi.org\/10.1172\/jci.insight.90954.","DOI":"10.1172\/jci.insight.90954"},{"issue":"3","key":"902_CR27","doi-asserted-by":"publisher","first-page":"100434","DOI":"10.1016\/j.patter.2022.100434","volume":"3","author":"D Osorio","year":"2022","unstructured":"Osorio D, Zhong Y, Li G, Xu Q, Yang Y, Tian Y, et al. scTenifoldknk: an efficient virtual knockout tool for gene function predictions via single-cell gene regulatory network perturbation. Patterns (N Y). 2022;3(3):100434. https:\/\/doi.org\/10.1016\/j.patter.2022.100434.","journal-title":"Patterns (N Y)"},{"key":"902_CR28","doi-asserted-by":"publisher","unstructured":"Newsome PN, Loomba R. Therapeutic horizons in metabolic dysfunction\u2013associated steatohepatitis. J Clin Invest. 2025;135(13). https:\/\/doi.org\/10.1172\/JCI186425.","DOI":"10.1172\/JCI186425"},{"issue":"1","key":"902_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11892-025-01579-1","volume":"25","author":"MW Takawy","year":"2025","unstructured":"Takawy MW, Abdelmalek MF. Impact of weight loss on metabolic dysfunction associated steatohepatitis and hepatic fibrosis. Curr Diab Rep. 2025;25(1):23. https:\/\/doi.org\/10.1007\/s11892-025-01579-1.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"902_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41420-024-02168-z","volume":"10","author":"HL Xu","year":"2024","unstructured":"Xu HL, Wan SR, An Y, Wu Q, Xing YH, Deng CH, et al. Targeting cell death in NAFLD: mechanisms and targeted therapies. Cell Death Discov. 2024;10(1):399. https:\/\/doi.org\/10.1038\/s41420-024-02168-z.","journal-title":"Cell Death Discov"},{"issue":"2","key":"902_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jhep.2023.10.025","volume":"80","author":"Z Lei","year":"2024","unstructured":"Lei Z, Yu J, Wu Y, Shen J, Lin S, Xue W, et al. CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis. J Hepatol. 2024;80(2):194\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.025.","journal-title":"J Hepatol"},{"issue":"5","key":"902_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","volume":"81","author":"V Taru","year":"2024","unstructured":"Taru V, Szabo G, Mehal W, Reiberger T. Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation. J Hepatol. 2024;81(5):895\u2013910. https:\/\/doi.org\/10.1016\/j.jhep.2024.06.016.","journal-title":"J Hepatol"},{"issue":"11","key":"902_CR33","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","volume":"35","author":"K Sawada","year":"2023","unstructured":"Sawada K, Chung H, Softic S, Moreno-Fernandez ME, Divanovic S. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metab. 2023;35(11):1852\u201371. https:\/\/doi.org\/10.1016\/j.cmet.2023.10.009.","journal-title":"Cell Metab"},{"key":"902_CR34","doi-asserted-by":"publisher","first-page":"1694892","DOI":"10.3389\/fimmu.2025.1694892","volume":"16","author":"M Rueda-Munguia","year":"2025","unstructured":"Rueda-Munguia M, Luevano-Martinez LA, Garcia-Rivas G, Castillo EC, Lozano O. Macrophages: their role in immunity and their relationship with fatty acids in health and disease. Front Immunol. 2025;16:1694892. https:\/\/doi.org\/10.3389\/fimmu.2025.1694892.","journal-title":"Front Immunol"},{"issue":"2","key":"902_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41590-024-02065-8","volume":"26","author":"M Belabed","year":"2025","unstructured":"Belabed M, Park MD, Blouin CM, Balan S, Moon CY, Freed G, et al. Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer. Nat Immunol. 2025;26(2):188\u201399. https:\/\/doi.org\/10.1038\/s41590-024-02065-8.","journal-title":"Nat Immunol"},{"key":"902_CR36","doi-asserted-by":"publisher","first-page":"1813173","DOI":"10.3389\/fimmu.2026.1813173","volume":"17","author":"GW Lin","year":"2026","unstructured":"Lin GW, Lin ZY, Su QY, Ye L, Xu WN, Nong SQ, et al. Integrated transcriptomic and single cell analysis combined with artificial neural network identifies a robust gene signature for early discrimination of MASL and MASH. Front Immunol. 2026;17:1813173. https:\/\/doi.org\/10.3389\/fimmu.2026.1813173.","journal-title":"Front Immunol"},{"issue":"12","key":"902_CR37","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1038\/s12276-023-01121-x","volume":"55","author":"J Yoon","year":"2023","unstructured":"Yoon J, Kim S, Lee M, Kim Y. Mitochondrial nucleic acids in innate immunity and beyond. Exp Mol Med. 2023;55(12):2508\u201318. https:\/\/doi.org\/10.1038\/s12276-023-01121-x.","journal-title":"Exp Mol Med"},{"issue":"1","key":"902_CR38","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1038\/s41467-023-44084-3","volume":"14","author":"N Gitego","year":"2023","unstructured":"Gitego N, Agianian B, Mak OW, Kumar Mv V, Cheng EH, Gavathiotis E. Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis. Nat Commun. 2023;14(1):8381. https:\/\/doi.org\/10.1038\/s41467-023-44084-3.","journal-title":"Nat Commun"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00902-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00902-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00902-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:40:06Z","timestamp":1792629606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00902-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["902"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00902-4","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures in this study were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Tsinghua University (Approval No. 25\u2013GHJ2). The experiments were performed in strict accordance with the ARRIVE guidelines 2.0 and the National Standard of the People\u2019s Republic of China (GB\/T 35892-2018, Guideline for Ethical Review of Laboratory Animal Welfare). All efforts were made to minimize animal suffering and reduce the number of animals used, in compliance with the 3\u2009R principles (Replacement, Reduction, and Refinement).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"212"}}